shu-508 and Endometrial-Neoplasms

shu-508 has been researched along with Endometrial-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for shu-508 and Endometrial-Neoplasms

Article	Year
[132 grams of tamoxifen: ultrasonographic and MRI appearance of endometrial carcinoma]. Journal de radiologie, 2001, Volume: 82, Issue:11 Endometrial carcinoma is a rare iatrogenic complication due to the adverse estrogenic like effect of Tamoxifen on the uterine mucosa. We report the delayed case of an endometrial carcinoma after an unusual twleve year long daily administration of Tamoxifen (cumulative dose = 131 g). Endovaginal contrast ultrasound examination (Levovist, Schering, Germany) and MRI appearances are described. Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Brachytherapy; Combined Modality Therapy; Contrast Media; Endometrial Neoplasms; Female; Humans; Hysterectomy; Iatrogenic Disease; Magnetic Resonance Imaging; Middle Aged; Polysaccharides; Postoperative Care; Radiotherapy Dosage; Tamoxifen; Time Factors; Ultrasonography	2001

Article

Year

[132 grams of tamoxifen: ultrasonographic and MRI appearance of endometrial carcinoma].

Journal de radiologie, 2001, Volume: 82, Issue:11

Endometrial carcinoma is a rare iatrogenic complication due to the adverse estrogenic like effect of Tamoxifen on the uterine mucosa. We report the delayed case of an endometrial carcinoma after an unusual twleve year long daily administration of Tamoxifen (cumulative dose = 131 g). Endovaginal contrast ultrasound examination (Levovist, Schering, Germany) and MRI appearances are described.

Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Brachytherapy; Combined Modality Therapy; Contrast Media; Endometrial Neoplasms; Female; Humans; Hysterectomy; Iatrogenic Disease; Magnetic Resonance Imaging; Middle Aged; Polysaccharides; Postoperative Care; Radiotherapy Dosage; Tamoxifen; Time Factors; Ultrasonography

2001